arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 4/2020 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Semaglutide (OZEMPIC) and other GLP-1 agonists in type 2 diabetes

    Romosozumab (EVENITY) for postmenopausal osteoporosis

    THERAPY FROM A CRITICAL VIEWPOINT

    ISCHEMIA trial: invasive or conservative treatment in stable coronary artery disease? (short version)

    IN BRIEF

    Varicella-zoster virus reactivation after vaccination with SHINGRIX?
    free

    Ranitidine (e.g. RANITIC) withdrawn from the market in the USA

    Ingenol mebutate (PICATO): approval withdrawn

    CURRENT ADR NETWORK REPORT

    Pruritus with new oral anticoagulants

    SIDE EFFECTS

    Severe liver damage with pirfenidone (ESBRIET)

    Fluorouracil cytostatics – screen for enzyme deficiency

    e a-t ON THE INTERNET

    Relocate production of drugs back to Germany and Europe respectively?

    Chloroquine and hydroxychloroquine in COVID-19?

    ISCHEMIA trial: invasive or conservative treatment in stable coronary artery disease? (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!